Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. - Wikidata - awgldk - TriplyDB

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin.

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin.

http://www.wikidata.org/entity/Q35155315

about

Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review Early Defensive Mechanisms against Human Papillomavirus Infection Papillomavirus prophylactic vaccines: established successes, new approaches.Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.Transcriptional repression of E-cadherin by human papillomavirus type 16 E6.High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions.Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis.Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity Unique features of antiviral immune system of the vaginal mucosa The Asian-American E6 variant protein of human papillomavirus 16 alone is sufficient to promote immortalization, transformation, and migration of primary human foreskin keratinocytes.The immune response to papillomavirus during infection persistence and regression.The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression.Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.Antiviral immune responses in the genital tract: clues for vaccines.High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.New Approaches to Immunotherapy for HPV Associated Cancers.Human papillomavirus molecular biology and disease association.Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice.T cell susceptibility to HIV influences outcome of opportunistic infections.Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling The human papillomavirus E7 oncoprotein as a regulator of transcription.DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells.Carcinogenic human papillomavirus infection.Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes.High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.Human tumour viruses and the deregulation of cell polarity in cancer.Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response.Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.Tacrolimus Reverses UVB Irradiation-Induced Epidermal Langerhans Cell Reduction by Inhibiting TNF-α Secretion in Keratinocytes via Regulation of NF-κB/p65.Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression.Oral manifestations of human papillomavirus infections

P2860

Q24792153-0550053F-F3F2-4479-85A3-7EE9423BA56F Q26852611-221E7FA5-83BC-4A8D-8E67-D48C1672BB54 Q33614425-4A7EA2F8-2EA9-4EA8-93F7-0C0E9EE3EA54 Q33829192-279C661F-14AE-49A5-A751-F987A4A89C89 Q34493735-35B88625-7A6C-40EE-B448-D504151268AA Q35053352-4F2884FF-C066-419A-BFDC-3EEA2E24BD5A Q35620761-68817B10-8459-4863-B9AB-621CFB9A0894 Q35737392-F4FF9661-631C-4797-93A5-BCB4D9C16788 Q35974911-7FE8A57D-E1D7-44A0-BAEA-D1B201E446F0 Q36177229-832F0E01-6764-4D22-94A6-094ED69BA567 Q36363871-5ED343D4-A61E-4140-8B0F-8EA2D4A7C889 Q36540399-91976D2B-BFB5-4F52-B947-E123B194E155 Q36541450-CBC8D5AD-0CDC-45D7-90B2-401D90AB03A8 Q36579864-A07189F9-E53F-41AF-82C0-61D4A6316F1F Q36729107-83B97C9F-0998-41A0-B02F-2B1F2EA7E799 Q36918159-519F6DEF-B580-470B-8D4B-72B254141315 Q37126213-0CEE486D-D828-4BE9-8E03-BF07E5B4A585 Q37137430-081500DA-A877-4336-8A52-FD483A5722EF Q37257349-DBDCBA31-BE6B-45E8-B037-B3D2B870D0EE Q37314669-CB1C7FAD-16C9-4491-AFCA-E06FE178AF1E Q37382387-2BA625B0-9F62-4695-B489-A612C30C0F7F Q37484492-A4A62F02-693E-49D5-91BE-50B40BCBCF4D Q39000409-50E672F2-EBFA-4ED0-9AC6-DCFB5BA667E6 Q39166828-2CFF3872-6469-4A0C-9AD3-BFF6A9708E41 Q39970535-E53C2AEE-1BDB-4E46-B270-6472E67A9241 Q40444191-78674567-F890-4485-A5C2-91730C9F0857 Q41847338-DE523BB3-C749-4E21-9575-9B62AF3D82CD Q42261545-F23DCE05-EE39-4D35-A10B-895A2C6E647E Q44863515-D6546397-E213-4629-B299-93197AB633F1 Q45158133-348F6600-662E-4DD8-B7E6-4FDD3BA90833 Q45420696-A273E7FF-6761-49A3-A46B-FCA200DAB549 Q46344926-4BAC2C6E-DA37-444D-8CF9-1E82F469FB7D Q48102982-B2717196-49F3-4493-910A-C1135A4F3A68 Q51000235-70FC46DD-1917-4A1D-8BDF-636597EEBB33 Q51742573-A57CAE27-4AB6-4A16-902A-0DF65D008A34 Q54527773-C9F07C53-7B9D-4FE5-9F39-E6DA69B4A9F0 Q58766185-600C0BE3-472B-46F2-85F4-0221D774F908

P2860

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin.

http://www.wikidata.org/entity/Q35155315

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@ast

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@en

type

label

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@ast

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@en

prefLabel

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@ast

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@en

P1433

Q35155315-C833796E-AA07-4848-85E8-894E04E251DC

P1476

Q35155315-6DBC1A9D-2F93-4265-AC7D-18A671936180

P2093

Q35155315-1252D39A-DDF2-4736-B26C-6C4A76C244F1

Q35155315-75C67BC9-957D-49F6-AA76-79B1518015F3

Q35155315-7CC74503-5101-41B3-95AD-A57641B4A182

Q35155315-7DA54A13-3693-4FD9-8C2A-F95B272E7478

Q35155315-81A91DF7-A60A-493A-9F81-EE10A34E2B26

Q35155315-D743CDFC-1227-4963-A41D-7762112A523B

Q35155315-F3CF9165-EDBE-4D0F-9B55-462A5082F0BA

Q35155315-FF96C41A-D7FD-4EBE-8899-02E23A0A32BA

P2860

Q35155315-0D604E3B-9CF4-49A9-865B-50D61ABF7A83

Q35155315-1D047D6C-3519-421B-AB8A-E74652633CE9

Q35155315-22F87EBA-EA73-426C-9FB8-81419D5169F4

Q35155315-2AEBBC05-35FA-400C-A603-B9B73AE0A8EB

Q35155315-2E4CD2ED-B58F-4731-A05F-C2617C1529F0

Q35155315-31990903-56CE-476D-B150-C44C014B0313

Q35155315-45058D03-359D-4C99-8392-6976F16DE3DB

Q35155315-482FDE81-565F-4087-AEE4-9BA39D3611EF

Q35155315-4A094A4A-0D81-468B-A894-6D9C446C7EA5

Q35155315-5FE42E7D-B628-4428-9125-C3C6800D2357

P304

Q35155315-BCDA1DBB-70C1-42AD-A86C-1B262F078E75

P31

Q35155315-A665CCA1-2CC9-4D3E-B82F-079FACB25731

P356

Q35155315-0DA016A5-507C-4CF9-8A09-781F9BC49F15

P407

Q35155315-B89EB639-6A70-4027-8F24-25533F973DAA

P433

Q35155315-71BBB88C-BACA-49E0-824F-8C2798AF23EB

P478

Q35155315-4C6ADE68-130B-4A43-9ACB-DF37891F61A7

P577

Q35155315-ACCF0C27-FD12-4B8C-A264-2716A8933B8D

P698

Q35155315-27348938-10BC-47E1-91DF-4683C1499038

P932

Q35155315-49D4275F-3A30-45F2-BFD3-86EE40E8DBB4

P356

JVI.77.15.8378-8385.2003

P1433

Journal of Virology

P1476

Depletion of Langerhans cells ...... down regulation of E-cadherin.

@en

P2093

B Thomas Bäckström

http://www.w3.org/2001/XMLSchema#string

Cheng Mee Leong

http://www.w3.org/2001/XMLSchema#string

Emma Inglis

http://www.w3.org/2001/XMLSchema#string

John Doorbar

http://www.w3.org/2001/XMLSchema#string

Kankatsu Yun

http://www.w3.org/2001/XMLSchema#string

Kate Matthews

http://www.w3.org/2001/XMLSchema#string

Lindsay Baxter

http://www.w3.org/2001/XMLSchema#string

Merilyn Hibma

http://www.w3.org/2001/XMLSchema#string

P2860

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

The steady-state turnover of murine epidermal Langerhans cells.

Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection

Immune evasion in human papillomavirus-associated cervical cancer.

Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups

Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.

Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.

P304

8378-8385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.15.8378-8385.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12857907

http://www.w3.org/2001/XMLSchema#string

P932

165258

http://www.w3.org/2001/XMLSchema#string